Douglas Lane & Associates’s QIAGEN NV QGENF Stock Holding History

Douglas Lane & Associates’s Portfolio QGENF Stock Details QGENF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-1,816,416	Closed	-$50.9M	–	215
2016 Q4	$50.9M	Sell	1,816,416 -31,260	-2%	-$876K	1.3%	26
2016 Q3	$50.7M	Sell	1,847,676 -95,002	-5%	-$2.61M	1.35%	24
2016 Q2	$42.4M	Buy	1,942,678 +21,675	+1%	+$473K	1.22%	29
2016 Q1	$42.9M	Buy	+1,921,003	New	+$42.9M	1.17%	29

Other funds holding QGENF

BJCM

Blue Jay Capital Management Los Angeles, California $147M AUM 64.18% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

GAM

Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Capital Fund Management (CFM) Paris, France $22.1B AUM 20.49% 1-Year Est. Return

Twin Tree Management Dallas, Texas $4.75B AUM 58.16% 1-Year Est. Return

Douglas Lane & Associates's QGENF Position: Q1 2017 in Review

Douglas Lane & Associates sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 1,816,416 shares — an estimated $50.9M sold.

Douglas Lane & Associates first reported a position in QGENF in Q1 2016 and held it in 4 quarters. The position peaked at $50.9M in Q4 2016. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.

Douglas Lane & Associates reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
Douglas Lane & Associates sold 1,816,416 QIAGEN NV shares in Q1 2017, an estimated $50.9M.
Douglas Lane & Associates first reported a position in QIAGEN NV in Q1 2016 and held it in 4 quarters.
Douglas Lane & Associates's QIAGEN NV position peaked at $50.9M in Q4 2016.
6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.

Based on Douglas Lane & Associates's 13F filing for Q1 2017, filed 21 Apr 2017.